Shares of RadNet Inc. (RDNT) surged by an impressive 24.12% on November 11, 2024, as the diagnostic imaging company announced a major partnership with GE HealthCare and reported strong third-quarter financial results.
The primary catalyst for RadNet's stock price surge was the strategic collaboration between its subsidiary, DeepHealth, and GE HealthCare. The two companies aim to develop AI-powered "SmartTechnology" solutions that leverage DeepHealth's AI-driven health informatics and GE HealthCare's imaging expertise. Their initial focus will be on integrating DeepHealth's SmartMammo AI solution with GE HealthCare's Senographe Pristina mammography system to enhance breast cancer screening.
RadNet CEO Howard Berger expressed excitement about the partnership, stating that it will "revolutionize large-scale diagnostic and screening programs, streamline radiology workflows, and improve patient outcomes." GE HealthCare CEO Roland Rott echoed similar sentiments, highlighting the potential of the collaboration to "elevate personalized breast care for those facing this difficult diagnosis."